Article Versions Notes

Kim B-H, Lee H, Park CG, Jeong AJ, Lee S-H, Noh KH, Park JB, Lee C-G, Paek SH, Kim H, et al. STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model. Cells. 2020; 9(3):722. https://doi.org/10.3390/cells9030722

Kim, Byung-Hak, Haeri Lee, Cheol Gyu Park, Ae Jin Jeong, Song-Hee Lee, Kum Hee Noh, Jong Bae Park, Chung-Gi Lee, Sun Ha Paek, Hyunggee Kim, and et al. 2020. "STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model" Cells 9, no. 3: 722. https://doi.org/10.3390/cells9030722

Kim, B.-H., Lee, H., Park, C. G., Jeong, A. J., Lee, S.-H., Noh, K. H., Park, J. B., Lee, C.-G., Paek, S. H., Kim, H., & Ye, S.-K. (2020). STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model. Cells, 9(3), 722. https://doi.org/10.3390/cells9030722